Work

Abstract 4643: Phase I pharmacokinetics and pharmacodynamics of a novel indenoisoquinoline topoisomerase 1 (TOP1) inhibitor, LMP400, administered on a daily x 5 schedule

Year: 2014

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2014-4643

Authors: Jan H. Beumer, Julianne Holleran, James Doroshow, Alice Chen, Deborah Allen, Joseph Covey, Joseph Tomaszewski, Yves Pommier, Shivaani Kumar, Julie L. Eiseman

Institutions: UPMC Hillman Cancer Center, National Institutes of Health

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2092981665

Cites:

Cited by: 1

Related to: 10